People are urged to expand their acceptance of vaccines when it comes to getting their vaccine.
This follows numerous cases in Chatham-Kent, Ontario and Canada of people refusing a photo when they learn it is not the brand they expected. The most common example now is to pass up a photo of Moderna instead of a preference for Pfizer.
“It’s about time we really embraced the mix,” says Medical Officer of Health Dr. David Colby. “Pfizer and Moderna are both mRNA vaccines, they use the same spike protein as their target. They are interchangeable. There has been a tremendous amount of provincial and national messages and expert opinions to support this.
The need for flexibility is essential for several reasons. One is the fluctuating supply figures. “Sometimes Pfizer is more abundant, sometimes Moderna is more abundant. Right now we have a situation where Moderna is more abundant than Pfizer, ”explains Colby.
Pfizer is also the only vaccine currently approved by Health Canada for the 12 to 17 age group. This segment is a priority so that the school in person has the best chance of success in September.
“We need to reserve the doses of Pfizer that we have – not all of them will be absorbed by this, but a large chunk of those allocations – for 12-17 year olds. Which means people have to be open to the idea of having a different brand, ”says Colby.
“And there really shouldn’t be any hesitation about it, they’re indistinguishable. They don’t have any significant differences in terms of efficacy or side effects or anything. They are both excellent vaccines.
“If you have to get somewhere and you call a cab, you shouldn’t decide to get in if a Chevrolet or a Ford shows up. They will both take you where you want to go. Climb on board. And roll up your sleeve.
Colby adds that people who have received a double dose of AstraZeneca should also be confident in their decision. For anyone debating whether to get their second dose this way, Colby says that much of what we do in our day-to-day lives carries a lot more risk than the low risk of side effects from blood clotting. vaccine.